Sanofi recognised by Dow Jones Sustainability Indices

Sanofi has been recognised for its corporate social responsibility performance through inclusion in the Dow Jones Sustainability Indices (DSJI).

The firm has been included in the DJSI World ranking for the ninth consecutive year, as well as being one of only five pharmaceutical companies selected for the DJSI Europe – a first for the company.

These indices assess companies' economic, social, societal and environmental performance in 24 distinct areas. This year, Sanofi scored 86 out of a possible 100, up from 84 last year.

Additionally, the company was recognised as best in class on several criteria, including strategy to improve access to drugs or products, health outcome contribution, bioethics, social reporting and stakeholder engagement.

Dr Olivier Brandicourt, chief executive officer at Sanofi, said: "We are very proud that Sanofi continues to be recognised as one of the most sustainable companies within the pharmaceutical sector. This success is a tribute to all our employees and their ongoing commitment to corporate social responsibility."

In 2014, more than 89 million patients received diagnosis, vaccination, treatment or self-disease management programmes across over 80 countries thanks to Sanofi.